Key informationMain study endpointsSafety: growth parameters, adverse eventsPopulation360 babiesTested productInfant...
Key informationMain study endpointsSafety: growth parameters, adverse eventsPopulation360 babiesTested productInfant...
Key informationObjectiveThe initial objective was to assess if the study product had an impact on microbiome...
Key informationMain study endpoints- Reduction in the incidence rate of infectious diarrhea - Modulation of intestinal...
International HumanMicrobiome Consortium Congress (IHMC)June, 27th to 29th 2021Biofortis is proud to announce that we will be silver sponsor to the IHMC 2021. We are looking forward to catching up...
For more information, don't hesitate to contact us :
New EasyBioM® V3 launch offer*!Try the new version and get 30% off your shotgun analyses !*EasyBioM® is the Biofortis application for customized visualization of metagenomic data. This offer is...
Lancement de l’Alliance Promotion MicrobioteLe 29 mars 2021 – L’Alliance Promotion Microbiote est lancée : fruit de l’union d’une quinzaine d’acteurs publics et privés engagés (instituts de...
31 mars 2021 de 9h30 à 12h : Atelier produits de santé et microbiomeA l’occasion du Printemps de la Recherche Clinique de l’AFCROs, Biofortis vous propose un atelier autour du thème “Le microbiome,...
Morgane Pierre, Sophie Le Fresne-Languille & Thomas Carton, Biofortis The nasal cavity is a highly complex air-filled space with several distinct zones. As the first part of therespiratory...